Patents by Inventor Christopher J.H. Davitt

Christopher J.H. Davitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11925681
    Abstract: Outer membrane vesicles from bacteria of the Burkholderia pseudomallei complex can be used as adjuvants in compositions and methods to potentiate the immune response to immunogens.
    Type: Grant
    Filed: December 26, 2022
    Date of Patent: March 12, 2024
    Assignee: The Administrators of the Tulane Educational Fund
    Inventors: Lisa Ann Morici, James B. McLachlan, Christopher J. H. Davitt, Jonathan R. Kurtz
  • Publication number: 20230405058
    Abstract: Provided herein are methods and compositions related to Prevotella EVs useful as therapeutic agents.
    Type: Application
    Filed: January 18, 2023
    Publication date: December 21, 2023
    Inventors: Brian Goodman, Baundauna Bose, Christopher J.H. Davitt, Sofia M.R. Carlton, William Caffry, Hank Wu
  • Publication number: 20230355689
    Abstract: Enterically-coated solid dosage forms containing a pharmaceutical agent which includes bacteria and/or microbial extracellular vesicles (mEVs) are provided. Methods of treatment using such solid dosage forms are also provided.
    Type: Application
    Filed: December 23, 2020
    Publication date: November 9, 2023
    Inventors: Christopher J. H. Davitt, Brian Goodman, Syed Altaf
  • Publication number: 20230210913
    Abstract: Provided herein are methods and compositions related to EVs useful as therapeutic agents.
    Type: Application
    Filed: December 2, 2022
    Publication date: July 6, 2023
    Inventors: Brian Goodman, Baundauna Bose, Christopher J.H. Davitt
  • Publication number: 20230146032
    Abstract: Outer membrane vesicles from bacteria of the Burkholderia pseudomallei complex can be used as adjuvants in compositions and methods to potentiate the immune response to immunogens.
    Type: Application
    Filed: December 26, 2022
    Publication date: May 11, 2023
    Applicant: Administrators of the Tulane Educational Fund
    Inventors: Lisa Ann MORICI, James B. McLACHLAN, Christopher J.H. DAVITT, Jonathan R. KURTZ
  • Patent number: 11534486
    Abstract: Outer membrane vesicles from bacteria of the Burkholderia pseudomallei complex can be used as adjuvants in compositions and methods to potentiate the immune response to immunogens.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: December 27, 2022
    Assignee: Administrators of the Tulane Educational Fund
    Inventors: Lisa Ann Morici, James B. McLachlan, Christopher J. H. Davitt, Jonathan R. Kurtz
  • Patent number: 11524037
    Abstract: Provided herein are methods and compositions related to EVs useful as therapeutic agents.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: December 13, 2022
    Assignee: Evelo Biosciences, Inc.
    Inventors: Brian Goodman, Baundauna Bose, Christopher J. H. Davitt
  • Publication number: 20220370599
    Abstract: In the various aspects and embodiments, this disclosure provides messenger RNA (mRNA) constructs for therapeutic delivery, as well as methods for making such mRNA constructs and pharmaceutical compositions comprising the same (including mRNA vaccine compositions). In still other aspects, the invention provides methods for treating patients by expression of therapeutic proteins, including for preventing or reducing probability of infection by, or illness involving, a virus. Exemplary viruses include coronaviruses (such as SARS-CoV-2 and variants therefore) and influenza viruses, among others.
    Type: Application
    Filed: May 2, 2022
    Publication date: November 24, 2022
    Inventors: James Robbins ABSHIRE, Christopher J.H. DAVITT, Ian HILL, Lorenzo AULISA, Marcelo SAMSA, Nabanita DE, Michael HUDSON, Rachit JAIN, Himanshu DHAMANKAR, William FARMER, Christopher GREGG
  • Publication number: 20220296654
    Abstract: Provided herein are methods and pharmaceutical compositions related to processed microbial extracellular vesicles (pmEVs) that can be useful as therapeutic agents.
    Type: Application
    Filed: June 11, 2020
    Publication date: September 22, 2022
    Inventors: Alicia Ballok, Mark Bodmer, Baundauna Bose, Sofia M. Carlton, Taylor A. Cormack, Christopher J.H. Davitt, Loise Francisco-Anderson, Brian Goodman, Andrea ltano, Nihal Okan, Holly Ponichtera, Erin B. Troy, Fabian B. Romano-Chernac, Maria Sizova
  • Patent number: 11090341
    Abstract: Provided herein are methods and compositions related to Veillonella bacteria useful as therapeutic agents.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: August 17, 2021
    Assignee: Evelo Biosciences, Inc.
    Inventors: Brian Goodman, Baundauna Bose, Christopher J. H. Davitt, Maria Sizova, Sofia M. R. Carlton, Andrea Itano, Holly Ponichtera, Taylor A. Cormack, Kritika Ramani
  • Publication number: 20210162033
    Abstract: Outer membrane vesicles from bacteria of the Burkholderia pseudomallei complex can be 5 used as adjuvants in compositions and methods to potentiate the immune response to immunogens.
    Type: Application
    Filed: April 10, 2019
    Publication date: June 3, 2021
    Applicant: Administrators of the Tulane Educational Fund
    Inventors: Lisa Ann MORICI, James B. McLACHLAN, Christopher J.H. DAVITT, Jonathan R. KURTZ
  • Publication number: 20200254028
    Abstract: Provided herein are methods and compositions related to EVs useful as therapeutic agents.
    Type: Application
    Filed: September 10, 2018
    Publication date: August 13, 2020
    Inventors: Brian GOODMAN, Baundauna BOSE, Christopher J.H. DAVITT
  • Publication number: 20190350987
    Abstract: Provided herein are methods and compositions related to Veillonella bacteria useful as therapeutic agents.
    Type: Application
    Filed: February 6, 2019
    Publication date: November 21, 2019
    Inventors: Brian Goodman, Baundauna Bose, Christopher J.H. Davitt, Maria Sizova, Sofia M.R. Carlton, Andrea Itano, Holly Ponichtera, Taylor A. Cormack
  • Publication number: 20190240263
    Abstract: Provided herein are methods and compositions related to Prevotella EVs useful as therapeutic agents.
    Type: Application
    Filed: September 10, 2018
    Publication date: August 8, 2019
    Inventors: Brian Goodman, Baundauna Bose, Christopher J. H. Davitt, Sofia M. R. Carlton, Will Caffry, Hank Wu